Question Bank › The feared thing keeps not happening

The feared thing keeps not happening

The feared thing keeps not happening: management confronts a specific live worry with current evidence running against i

Calls Tested
994
Answered YES
93
Hit Rate
9.4%
rare by design

Cleveland-Cliffs Inc. (CLF) — this company's answers

NO on the Q1 2016 call 2016-04-29 F
The model's full reasoning — Q1 2016 call → NO我们根据提供的电话会议记录,判断是否存在一个具体的、公司特定的负面担忧,以及管理层是否用已经观察到的证据来反驳这一担忧。 首先,寻找公司特定的担忧。在电话会议中,分析师和Lourenco Goncalves多次提到一些担忧,例如: - 关于ArcelorMittal合同续签的担忧(分析师Nick Jarmoszuk问及,Lourenco回应说正在谈判,但尚未签署,但进展顺利)。 - 关于U.S. Steel可能成为竞争对手的担忧(Lourenco回应说U.S. Steel没有开发定制球团,且其客户U.S. Steel Canada已成为Cliffs客户)。 - 关于铁矿石价格下跌的担忧(分析师们提到价格预测,Lourenco反驳说价格不会低于$45,并批评银行预测)。 - 关于Essar Minnesota可能成为竞争对手的担忧(Lourenco提到Essar Minnesota没有启动,且他未收到邀请)。 但我们需要一个“具体的、公司特定的、现在活跃的担忧”,并且管理层用“已经观察到的证据”来反驳。 在电话会议中,最明显的担忧可能是关于ArcelorMittal合同续签的担忧,因为这是公司最大的客户(约900万吨/年)。分析师问及此事,Lourenco回应说正在开发Mustang球团,并投资改造UTAC,但合同尚未签署,不过他们不急于完成。这似乎是一个担忧,但管理层的回应是“我们正在合作,不急于”,这更多是信心而非已观察到的证据。 另一个担忧可能是关于U.S. Steel可能出售球团或成为竞争对手,但Lourenco说U.S. Steel没有开发定制球团,且其前客户已成为Cliffs客户,这算是已观察到的证据(U.S. Steel Canada成为客户)。 还有关于铁矿石价格下跌的担忧,但那是宏观的,不是公司特定的。 更具体的是,分析师们反复询问关于APIO业务和铁矿石价格,但那是行业性的。 在电话会议中,有一个明显的担忧是:公司能否维持其客户关系,特别是ArcelorMittal的续签。但管理层没有提供已签署的合同,只是说正在开发产品,并投资改造。这不算已观察到的证据。 另一个担忧是:公司能否应对来自U.S. Steel或Essar的竞争。Lourenco说U.S. Steel没有开发定制球团,Essar没有启动,这算是已观察到的证据(竞争对手没有行动)。 但我们需要一个“担忧”是“市场一直在担心的”,并且管理层用“已经发生的事实”来反驳。 在电话会议中,Lourenco多次提到他预测BHP和Rio Tinto的高管被解雇,这算是他之前的预测成真,但这不是对公司的担忧。 也许最接近的是:分析师担心铁矿石价格会下跌,但Lourenco反驳说价格不会低于$45,并指出主要矿商削减产量,这算是已观察到的证据(BHP、Rio Tinto、Vale宣布减产)。但这是行业性的,不是公司特定的。 再仔细看,有一个担忧是:公司能否维持其17.5百万吨的销量预测,特别是关于Algoma和U.S. Steel Canada的供应。Lourenco说这些已经包括在预测中,并且已经实现(U.S. Steel Canada已开始供应,Algoma将在Q3重启)。这算是已观察到的证据。 但这是否是“市场担心的”?分析师没有直接问及这个,而是问及ArcelorMittal。 也许更明确的是:分析师问及U.S. Steel可能成为竞争对手,Lourenco说U.S. Steel没有开发定制球团,且其前客户已成为Cliffs客户,这算是已观察到的证据。 但我们需要一个“担忧”是“现在活跃的”,并且管理层用“已经发生”来反驳。 在电话会议中,有一个明显的担忧是:公司能否续签ArcelorMittal合同。分析师问及,Lourenco说正在开发Mustang球团,并投资改造,但合同尚未签署。这不算已观察到的证据,因为合同还没签。 另一个担忧是:公司能否应对铁矿石价格下跌。但那是宏观的。 也许最符合的是:分析师担心公司会发行股票来偿还债务,但Lourenco说他会保护股东,但没有具体证据。 我认为没有完全符合的。因为管理层在回应担忧时,更多是信心和计划,而不是已经观察到的证据。例如,对于ArcelorMittal,他说“我们正在合作,不急于”,但没有说“他们已经续签了”。对于U.S. Steel,他说“没有开发定制球团”,这算是证据,但那是关于竞争对手的,不是关于公司自身的。 另外,关于Essar,他说“没有启动”,也是证据。 但我们需要一个“担忧”是“市场担心的”,并且管理层用“已经发生”来反驳。也许关于Algoma和U.S. Steel Canada的供应,管理层说这些已经包括在预测中,并且已经实现,这算是证据。但分析师没有直接问及这个。 在电话会议中,分析师问及ArcelorMittal,问及U.S. Steel,问及APIO,问及铁矿石价格。但管理层在回应时,有时用已观察到的证据,有时用信心。 例如,对于U.S. Steel,Lourenco说“U.S. Steel Canada已成为Cliffs客户”,这是已发生的。对于Essar,他说“没有启动”,也是已发生的。但这些都是关于竞争对手的,不是关于公司自身的担忧。 也许有一个担忧是:公司能否维持其成本削减,但那是正面的。 我认为没有完全符合的。因为担忧是具体的,但管理层的回应往往不是用已观察到的证据,而是用信心和计划。 再读一遍,在电话会议中,分析师问及ArcelorMittal时,Lourenco说“我们正在开发Mustang球团,并投资改造”,但合同未签。这不算已观察到的证据。 分析师问及U.S. Steel时,Lourenco说“U.S.

← Back to the full CLF analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company — a worry that is live on this call, evident either because analysts keep probing it or because management itself names it as a concern others hold — AND does management push back on that worry by pointing to CURRENT, ALREADY-OBSERVED evidence from the business showing that the feared outcome is, so far, NOT materializing? Answer YES when BOTH halves come through in the transcript as one coherent dynamic, in whatever form fits the business: (1) A NAMED, COMPANY-SPECIFIC FEAR THAT IS LIVE NOW. The worry is concrete and attached to this company — for example: that demand will fall off after an unusually strong stretch; that a major customer, contract, or partner will shrink, leave, or not renew; that a competitor, new technology, or cheaper alternative will take the company's business; that a key product, franchise, or pricing level is about to erode; that recent growth is a one-time bulge that will reverse; or another identifiable adverse outcome the market has been bracing for. The fear must be visible on the call itself — analysts returning to it in their questions, or management acknowledging in its own words that this is what people are worried about — not merely a generic risk factor or ordinary caution. (2) MANAGEMENT ANSWERS WITH OBSERVED BEHAVIOR, NOT REASSURANCE. Management responds by citing things that have ALREADY HAPPENED or are happening now — customers renewing, reordering, or expanding when they were expected to leave; demand holding or growing through the period when a drop-off was predicted; the threatened product, customer, or pricing actually performing in the recent period; competitive losses that have not shown up in real accounts; the feared cliff period arriving and being cleared — described with enough concrete substance (who, what, how much, or compared to when) that the rebuttal rests on evidence from the business rather than on confidence, promises, arguments about why the fear is illogical, or projections that the future will be fine. Answer NO if no specific company-attached worry is visible on the call — a routinely healthy company fielding ordinary questions is not this. Answer NO if the fear is visible but management's response is mainly reassurance, optimism, plans, or forecasts without already-observed evidence against it. Answer NO if the evidence shows the feared outcome IS materializing and management is excusing, minimizing, or promising to fix it. Answer NO if the worry is only broad macro or industry-wide gloom with nothing specific to this company's own business. Answer NO if management concedes the fear is valid and pivots to a different story instead of countering it. Answer NO if the counter-evidence is only a single vague assertion (such as 'demand remains strong') with no concrete grounding in what has actually occurred. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
AVTR Avantor, Inc. Q2 2024 2024-07-26 C+
IFS Intercorp Financial Services Inc. Q1 2024 2024-05-14 C+
AZEK The AZEK Company Inc. Q2 2024 2024-05-08 B+
GL Globe Life Inc. Q1 2024 2024-04-23 F
MNKD MannKind Corporation Q4 2023 2024-02-27 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
TYGO Tigo Energy, Inc. Q4 2023 2024-02-14 F
MET MetLife, Inc. Q4 2023 2024-02-01 B+
BBVA Banco Bilbao Vizcaya Argentaria, S.A. Q4 2023 2024-01-30 B+
TBLA Taboola.com Ltd. Q3 2023 2023-11-08 B+
GMED Globus Medical, Inc. Q3 2023 2023-11-07 B
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
MAC The Macerich Company Q3 2023 2023-10-31 D
LNTH Lantheus Holdings, Inc. Q2 2023 2023-08-03 C+
SITM SiTime Corporation Q2 2023 2023-08-02 C+
TREX Trex Company, Inc. Q2 2023 2023-07-31 B+
REYN Reynolds Consumer Products Inc. Q1 2023 2023-05-10 C
DOCN DigitalOcean Holdings, Inc. Q1 2023 2023-05-09 C+
ULCC Frontier Group Holdings, Inc. Q1 2023 2023-05-07 C+
AKR Acadia Realty Trust Q4 2022 2023-05-06 B+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
EPR EPR Properties Q1 2023 2023-04-27 C+
MEDP Medpace Holdings, Inc. Q1 2023 2023-04-25 B+
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
CRBG Corebridge Financial, Inc. Q4 2022 2023-02-22 B
POOL Pool Corporation Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
REGN Regeneron Pharmaceuticals, Inc. Q4 2022 2023-02-03 C
HBAN Huntington Bancshares Incorporated Q4 2022 2023-01-20 B
A Agilent Technologies, Inc. Q4 2022 2022-11-21 B+
PCTY Paylocity Holding Corporation Q1 2023 2022-11-05 A
TT Trane Technologies plc Q3 2022 2022-11-02 A
APOG Apogee Enterprises, Inc. Q2 2023 2022-09-20 A
CRL Charles River Laboratories International Q2 2022 2022-08-03 C
SGRY Surgery Partners, Inc. Q2 2022 2022-08-02 B+
ZBRA Zebra Technologies Corporation Q2 2022 2022-08-02 C+
LIN Linde plc Q2 2022 2022-07-28 B+
SHW The Sherwin-Williams Company Q2 2022 2022-07-27 D
JBHT J.B. Hunt Transport Services, Inc. Q2 2022 2022-07-19 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
SE Sea Limited Q1 2022 2022-05-17 F
DCGO DocGo Inc. Q1 2022 2022-05-14 C
ZVIA Zevia PBC Q1 2022 2022-05-12 B
EGHT 8x8, Inc. Q4 2022 2022-05-10 C+
CCRN Cross Country Healthcare, Inc. Q1 2022 2022-05-04 B
ABNB Airbnb, Inc. Q1 2022 2022-05-03 B+
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
BSX Boston Scientific Corporation Q1 2022 2022-04-27 B
CCK Crown Holdings, Inc. Q1 2022 2022-04-26 C+
FR First Industrial Realty Trust, Inc. Q1 2022 2022-04-21 A
SDIG Stronghold Digital Mining, Inc. Q3 2021 2021-11-30 F
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
IPGP IPG Photonics Corporation Q3 2021 2021-11-02 C
HSY The Hershey Company Q3 2021 2021-10-28 C
PEP PepsiCo, Inc. Q3 2021 2021-10-05 B
GDS GDS Holdings Limited Q2 2021 2021-08-17 C+
PTVE Pactiv Evergreen Inc. Q2 2021 2021-08-08 C+
SPG Simon Property Group, Inc. Q2 2021 2021-08-02 B
GLW Corning Incorporated Q2 2021 2021-07-27 B+
DOV Dover Corporation Q2 2021 2021-07-20 B+
VLRS Controladora Vuela Compañía de Aviación, Q2 2021 2021-07-16 B+
MAR Marriott International, Inc. Q2 2018 2018-08-07 B
VALE Vale S.A. Q2 2018 2018-07-26 B
FICO Fair Isaac Corporation Q3 2018 2018-07-26 C+
ORAN Orange SA Q2 2018 2018-07-26 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
TRUE TrueCar, Inc. Q1 2018 2018-05-08 C
TGNA TEGNA Inc. Q1 2018 2018-05-08 B+
CVS CVS Health Corporation Q1 2018 2018-05-02 B+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
MIDD The Middleby Corporation Q4 2017 2018-02-28 C
SBUX Starbucks Corporation Q1 2018 2018-01-26 C
AVT Avnet, Inc. Q2 2018 2018-01-25 B
GURE Gulf Resources, Inc. Q3 2017 2017-11-14 F
HOLX Hologic, Inc. Q4 2017 2017-11-08 D
MKTX MarketAxess Holdings Inc. Q3 2017 2017-10-25 C+
PII Polaris Inc. Q3 2017 2017-10-24 C+
LIND Lindblad Expeditions Holdings, Inc. Q2 2017 2017-08-06 C
BCRX BioCryst Pharmaceuticals, Inc. Q1 2017 2017-05-07 B
ICFI ICF International, Inc. Q1 2017 2017-05-06 B+
CGNT Cognyte Software Ltd. Q4 2016 2017-03-09 D
BDC Belden Inc. Q4 2016 2017-02-02 B
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
TGI Triumph Group, Inc. Q2 2017 2016-11-03 C+
SEM Select Medical Holdings Corporation Q1 2016 2016-05-06 C+
LPSN LivePerson, Inc. Q1 2016 2016-05-04 B
UVE Universal Insurance Holdings, Inc. Q1 2016 2016-05-03 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
VRTS Virtus Investment Partners, Inc. Q1 2016 2016-04-29 D
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
BX Blackstone Inc. Q1 2016 2016-04-21 B
HPP Hudson Pacific Properties, Inc. Q4 2015 2016-02-25 C

How the model reasoned

TGI · Q2 2017 → YESThe question is: Is there a specific negative outcome that investors/analysts/market are worried about for THIS company, live on this call, and does management push back with CURRENT, ALREADY-OBSERVED...YES The specific, company-attached fear that is live on the call is that Triumph will continue to face large performance-related charges, cash burn on development programs, and failure to stabilize margins/cash flow despite the transformation (a worry analysts repeatedly probe via questions on the $80M risk, free-cash-use guidance, 747-8/C-17/G650 headwinds, and red programs). Management directly counters it by citing already-observed evidence: Q2 operating income of $70.
ULCC · Q1 2023 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors/analysts/market have been worried about for THIS company, live on this call, AND does management push back with CURRENT, ALREADY-OB...YES The transcript shows a live, company-specific worry about pilot staffing shortages (tied to network changes and new contracts elsewhere) and customer churn/retention due to lower satisfaction scores. Management directly counters both with current evidence: pilot surplus and attrition on target for staffing, plus over 90% repeat business for retention.
HOLX · Q4 2017 → YESThe question is: Is there a SPECIFIC NEGATIVE OUTCOME that investors, analysts, or the market have plainly been worried will happen to THIS company, and does management push back on that worry by poin...YES The transcript shows a live, company-specific fear centered on Cynosure: investors and analysts are worried that the acquisition will not deliver sustainable growth, that recent sequential declines reflect a lasting salesforce collapse or competitive erosion, and that the business will continue underperforming expectations rather than turning around.

More from the question bank

Doors opening at the company's own gatesReporting the counterparty's growth as its oSecond proving already underwayNew normal declared and staffedBigger than they can carry aloneDemand arrived first, the company is growingAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.